Substituted Azoanthracene Derivatives and Intermediates for Preparation Thereof

The present invention relates to substituted azoanthracene derivatives and intermediates for the preparation thereof. The substituted azoanthracene derivatives and associated intermediates may be useful for the preparation of pharmaceutical compositions for the treatment or prevention of diseases, d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BONDLELA MURALIDHAR, ANDREWS ROBERT CARL, CHRISTEN DANIEL P, DAVIS STEPHEN THOMAS, BEHME CHRISTOPHER, YARRAGUNTA RAVINDRA REDDY, KALPATHY SANTHOSH, YOKUM THOMAS SCOTT, MJALLI ADNAN M.M, GUZEL MUSTAFA, QUADA, JR. JAMES C, GOHIMUKKULA DEVI REDDY, FREEMAN JENNIFER L.R, POLISETTI DHARMA RAO
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BONDLELA MURALIDHAR
ANDREWS ROBERT CARL
CHRISTEN DANIEL P
DAVIS STEPHEN THOMAS
BEHME CHRISTOPHER
YARRAGUNTA RAVINDRA REDDY
KALPATHY SANTHOSH
YOKUM THOMAS SCOTT
MJALLI ADNAN M.M
GUZEL MUSTAFA
QUADA, JR. JAMES C
GOHIMUKKULA DEVI REDDY
FREEMAN JENNIFER L.R
POLISETTI DHARMA RAO
description The present invention relates to substituted azoanthracene derivatives and intermediates for the preparation thereof. The substituted azoanthracene derivatives and associated intermediates may be useful for the preparation of pharmaceutical compositions for the treatment or prevention of diseases, disorders, and conditions wherein modulation of the human GLP-1 receptor is beneficial.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2015148539A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2015148539A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2015148539A13</originalsourceid><addsrcrecordid>eNrjZPAPLk0qLsksKS1JTVFwrMpPzCvJKEpMTs1LVXBJLcosSyzJLEstVkjMS1HwzCtJLcpNTclMLAGKpOUXKQQUpRYkFgGV5OcphGSkFqXmp_EwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTiArDRJfGhwUYGhqaGJhamxpaOhsbEqQIAmUA4mQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Substituted Azoanthracene Derivatives and Intermediates for Preparation Thereof</title><source>esp@cenet</source><creator>BONDLELA MURALIDHAR ; ANDREWS ROBERT CARL ; CHRISTEN DANIEL P ; DAVIS STEPHEN THOMAS ; BEHME CHRISTOPHER ; YARRAGUNTA RAVINDRA REDDY ; KALPATHY SANTHOSH ; YOKUM THOMAS SCOTT ; MJALLI ADNAN M.M ; GUZEL MUSTAFA ; QUADA, JR. JAMES C ; GOHIMUKKULA DEVI REDDY ; FREEMAN JENNIFER L.R ; POLISETTI DHARMA RAO</creator><creatorcontrib>BONDLELA MURALIDHAR ; ANDREWS ROBERT CARL ; CHRISTEN DANIEL P ; DAVIS STEPHEN THOMAS ; BEHME CHRISTOPHER ; YARRAGUNTA RAVINDRA REDDY ; KALPATHY SANTHOSH ; YOKUM THOMAS SCOTT ; MJALLI ADNAN M.M ; GUZEL MUSTAFA ; QUADA, JR. JAMES C ; GOHIMUKKULA DEVI REDDY ; FREEMAN JENNIFER L.R ; POLISETTI DHARMA RAO</creatorcontrib><description>The present invention relates to substituted azoanthracene derivatives and intermediates for the preparation thereof. The substituted azoanthracene derivatives and associated intermediates may be useful for the preparation of pharmaceutical compositions for the treatment or prevention of diseases, disorders, and conditions wherein modulation of the human GLP-1 receptor is beneficial.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150528&amp;DB=EPODOC&amp;CC=US&amp;NR=2015148539A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150528&amp;DB=EPODOC&amp;CC=US&amp;NR=2015148539A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BONDLELA MURALIDHAR</creatorcontrib><creatorcontrib>ANDREWS ROBERT CARL</creatorcontrib><creatorcontrib>CHRISTEN DANIEL P</creatorcontrib><creatorcontrib>DAVIS STEPHEN THOMAS</creatorcontrib><creatorcontrib>BEHME CHRISTOPHER</creatorcontrib><creatorcontrib>YARRAGUNTA RAVINDRA REDDY</creatorcontrib><creatorcontrib>KALPATHY SANTHOSH</creatorcontrib><creatorcontrib>YOKUM THOMAS SCOTT</creatorcontrib><creatorcontrib>MJALLI ADNAN M.M</creatorcontrib><creatorcontrib>GUZEL MUSTAFA</creatorcontrib><creatorcontrib>QUADA, JR. JAMES C</creatorcontrib><creatorcontrib>GOHIMUKKULA DEVI REDDY</creatorcontrib><creatorcontrib>FREEMAN JENNIFER L.R</creatorcontrib><creatorcontrib>POLISETTI DHARMA RAO</creatorcontrib><title>Substituted Azoanthracene Derivatives and Intermediates for Preparation Thereof</title><description>The present invention relates to substituted azoanthracene derivatives and intermediates for the preparation thereof. The substituted azoanthracene derivatives and associated intermediates may be useful for the preparation of pharmaceutical compositions for the treatment or prevention of diseases, disorders, and conditions wherein modulation of the human GLP-1 receptor is beneficial.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPAPLk0qLsksKS1JTVFwrMpPzCvJKEpMTs1LVXBJLcosSyzJLEstVkjMS1HwzCtJLcpNTclMLAGKpOUXKQQUpRYkFgGV5OcphGSkFqXmp_EwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTiArDRJfGhwUYGhqaGJhamxpaOhsbEqQIAmUA4mQ</recordid><startdate>20150528</startdate><enddate>20150528</enddate><creator>BONDLELA MURALIDHAR</creator><creator>ANDREWS ROBERT CARL</creator><creator>CHRISTEN DANIEL P</creator><creator>DAVIS STEPHEN THOMAS</creator><creator>BEHME CHRISTOPHER</creator><creator>YARRAGUNTA RAVINDRA REDDY</creator><creator>KALPATHY SANTHOSH</creator><creator>YOKUM THOMAS SCOTT</creator><creator>MJALLI ADNAN M.M</creator><creator>GUZEL MUSTAFA</creator><creator>QUADA, JR. JAMES C</creator><creator>GOHIMUKKULA DEVI REDDY</creator><creator>FREEMAN JENNIFER L.R</creator><creator>POLISETTI DHARMA RAO</creator><scope>EVB</scope></search><sort><creationdate>20150528</creationdate><title>Substituted Azoanthracene Derivatives and Intermediates for Preparation Thereof</title><author>BONDLELA MURALIDHAR ; ANDREWS ROBERT CARL ; CHRISTEN DANIEL P ; DAVIS STEPHEN THOMAS ; BEHME CHRISTOPHER ; YARRAGUNTA RAVINDRA REDDY ; KALPATHY SANTHOSH ; YOKUM THOMAS SCOTT ; MJALLI ADNAN M.M ; GUZEL MUSTAFA ; QUADA, JR. JAMES C ; GOHIMUKKULA DEVI REDDY ; FREEMAN JENNIFER L.R ; POLISETTI DHARMA RAO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2015148539A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>BONDLELA MURALIDHAR</creatorcontrib><creatorcontrib>ANDREWS ROBERT CARL</creatorcontrib><creatorcontrib>CHRISTEN DANIEL P</creatorcontrib><creatorcontrib>DAVIS STEPHEN THOMAS</creatorcontrib><creatorcontrib>BEHME CHRISTOPHER</creatorcontrib><creatorcontrib>YARRAGUNTA RAVINDRA REDDY</creatorcontrib><creatorcontrib>KALPATHY SANTHOSH</creatorcontrib><creatorcontrib>YOKUM THOMAS SCOTT</creatorcontrib><creatorcontrib>MJALLI ADNAN M.M</creatorcontrib><creatorcontrib>GUZEL MUSTAFA</creatorcontrib><creatorcontrib>QUADA, JR. JAMES C</creatorcontrib><creatorcontrib>GOHIMUKKULA DEVI REDDY</creatorcontrib><creatorcontrib>FREEMAN JENNIFER L.R</creatorcontrib><creatorcontrib>POLISETTI DHARMA RAO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BONDLELA MURALIDHAR</au><au>ANDREWS ROBERT CARL</au><au>CHRISTEN DANIEL P</au><au>DAVIS STEPHEN THOMAS</au><au>BEHME CHRISTOPHER</au><au>YARRAGUNTA RAVINDRA REDDY</au><au>KALPATHY SANTHOSH</au><au>YOKUM THOMAS SCOTT</au><au>MJALLI ADNAN M.M</au><au>GUZEL MUSTAFA</au><au>QUADA, JR. JAMES C</au><au>GOHIMUKKULA DEVI REDDY</au><au>FREEMAN JENNIFER L.R</au><au>POLISETTI DHARMA RAO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Substituted Azoanthracene Derivatives and Intermediates for Preparation Thereof</title><date>2015-05-28</date><risdate>2015</risdate><abstract>The present invention relates to substituted azoanthracene derivatives and intermediates for the preparation thereof. The substituted azoanthracene derivatives and associated intermediates may be useful for the preparation of pharmaceutical compositions for the treatment or prevention of diseases, disorders, and conditions wherein modulation of the human GLP-1 receptor is beneficial.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2015148539A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title Substituted Azoanthracene Derivatives and Intermediates for Preparation Thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T09%3A32%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BONDLELA%20MURALIDHAR&rft.date=2015-05-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2015148539A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true